Radiotherapy provider Nucletron has signed an agreement with RaySearch Laboratories of Stockholm, Sweden, for a long-term collaboration on the integration and licensing of RaySearch’s intensity-modulated radiation therapy (IMRT) optimization software.
The agreement will allow Nucletron to integrate RaySearch’s ORBIT optimization modules and future developments as part of its Oncentra Treatment Planning software, according to the Veenendaal, Netherlands-based firm.
January 20, 2004
Related Reading
Nucletron gets FDA clearance for Swift, August 21, 2003
Siemens and Nucletron to partner, August 7, 2003
Nucletron books 1,000th Simulix sale, April 10, 2003
Nucletron adds Merry X-Ray, December 10, 2002
Nucletron product gets FDA 510(k) clearance, November 20, 2002
Copyright © 2004 AuntMinnie.com
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&fit=crop&h=100&q=70&w=100)
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
